290 web-programmer-developer-"U"-"Washington-University-in-St" positions at Stanford University
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
cell fate decisions, particularly during early neural development or during the epithelial-to-mesenchymal transition (EMT) in cancer. Our recent work reveals that coding sequences (CDS) and their cognate
-
Substitution in the Blind; Ocular Structures and Physiology; MR Engineering and Methods Development for the Visual System. MRI experiments will mainly be conducted at research centers at the Stanford campus and
-
immunosuppression, akin to PDL1-PD1 interactions. In collaboration with Carolyn Bertozzi’s group, we are developing bifunctional proteins that include an antibody to cell surface cancer proteins (e.g. PSMA, CA9) and
-
to Laboratory Research in Neuronal Cell Biology in the Fall and Winter Quarters and assist with developing the course for future expansion. These courses provide hands-on research experiences for undergraduates
-
federally funded, interdisciplinary research program focused on improving healthcare delivery by studying and intervening in the human systems that support it. Based in the HEAL and Kim Labs at Stanford
-
Program at the Stanford Cancer Institute. She has an academic interest in Precision Medicine and her lab applies cutting-edge sequencing and imaging technologies to better understand skin cancer and rare
-
of physicists, engineers, and oceanographers interested in advancing our understanding of ocean science, water sustainability, and climate resilience. Our lab develops optical techniques based on spectroscopy
-
language processing (NLP) to augment clinical decision-making and expand access to high-quality healthcare. Our lab develops new methods to improve model trustworthiness and leverages heterogeneous clinical data
-
the Divisions of Immunology and Rheumatology and Pain Medicine. The fellow will have access to a collaborative environment and institutional resources supporting career development in academic medicine, including
-
(Siglecs) on immune cells to effect immunosuppression, akin to PDL1-PD1 interactions. In collaboration with Carolyn Bertozzi’s group, we are developing bifunctional proteins that include an antibody to cell